Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1883 1
1887 1
1891 1
1897 3
1898 1
1904 2
1905 1
1968 1
1974 2
1975 3
1976 1
1979 4
1980 4
1982 1
1983 1
1984 3
1985 2
1986 1
1987 4
1988 3
1989 3
1990 3
1991 2
1992 4
1993 1
1994 4
1995 7
1996 1
1997 3
1998 3
1999 6
2000 4
2001 3
2002 3
2003 5
2004 8
2005 4
2006 4
2007 2
2008 6
2009 1
2010 3
2012 4
2013 1
2014 1
2015 4
2016 3
2017 4
2018 4
2019 4
2020 3
2021 3
2022 2
2023 8
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
Wu YL, Tsuboi M, He J, John T, Grohe C, Majem M, Goldman JW, Laktionov K, Kim SW, Kato T, Vu HV, Lu S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, Shepherd FA, Zeng L, Hodge R, Atasoy A, Rukazenkov Y, Herbst RS; ADAURA Investigators. Wu YL, et al. N Engl J Med. 2020 Oct 29;383(18):1711-1723. doi: 10.1056/NEJMoa2027071. Epub 2020 Sep 19. N Engl J Med. 2020. PMID: 32955177 Clinical Trial.
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, Wang J, Goldman JW, Lu S, Su WC, de Marinis F, Shepherd FA, Lee KH, Le NT, Dechaphunkul A, Kowalski D, Poole L, Bolanos A, Rukazenkov Y, Wu YL; ADAURA Investigators. Tsuboi M, et al. N Engl J Med. 2023 Jul 13;389(2):137-147. doi: 10.1056/NEJMoa2304594. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272535 Clinical Trial.
Male development.
Emmons SW. Emmons SW. WormBook. 2005 Nov 10:1-22. doi: 10.1895/wormbook.1.33.1. WormBook. 2005. PMID: 18050419 Free PMC article. Review.
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH; ACT IV trial investigators. Weller M, et al. Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23. Lancet Oncol. 2017. PMID: 28844499 Free article. Clinical Trial.
Connectomics, the Final Frontier.
Emmons SW. Emmons SW. Curr Top Dev Biol. 2016;116:315-30. doi: 10.1016/bs.ctdb.2015.11.001. Epub 2016 Feb 27. Curr Top Dev Biol. 2016. PMID: 26970626 Free PMC article. Review.
Mechanisms of C. elegans development.
Emmons SW. Emmons SW. Cell. 1987 Dec 24;51(6):881-3. doi: 10.1016/0092-8674(87)90574-5. Cell. 1987. PMID: 3319188 Review. No abstract available.
Whole-animal connectomes of both Caenorhabditis elegans sexes.
Cook SJ, Jarrell TA, Brittin CA, Wang Y, Bloniarz AE, Yakovlev MA, Nguyen KCQ, Tang LT, Bayer EA, Duerr JS, Bülow HE, Hobert O, Hall DH, Emmons SW. Cook SJ, et al. Among authors: emmons sw. Nature. 2019 Jul;571(7763):63-71. doi: 10.1038/s41586-019-1352-7. Epub 2019 Jul 3. Nature. 2019. PMID: 31270481 Free PMC article.
162 results